Implantable cardioverter-defibrillators (ICDs) are increasingly used in patients ≥80 years old, and the proportion of devices incorporating cardiac resynchronization therapy (CRT) increases with patient age. In this era of patient-centered care, important questions arise about the patterns of use, clinical outcomes and cost-effectiveness of CRT for older patients. Currently, few data are available that specifically address the effects of CRT in the elderly.
The prevalence of congestive heart failure (HF) increases with age:
HF is implicated in 20% of hospital admissions in those aged >65, and octogenarians are 20 times more likely to be hospitalised for HF than younger patients. 1 As a consequence, elderly patients currently represent a larger portion of patients with HF, but they substantially differ from younger patients in both concurrent comorbid conditions and prescribed medical therapy. Cardiac resynchronization therapy (CRT) has been shown to improve symptoms and cardiac function, decrease cardiovascular and arrhythmic mortality and HF events in patients with wide QRS, low left ventricular ejection fraction (LVEF), and is also effective in less symptomatic patients. Therefore, CRT is a well-established therapy for HF patients, and its indications have recently been extended to patients in New York Heart Association (NYHA) class II. (death or HF) among subjects aged 60-74 years and ≥75 years, and this reduction was not significant in patients younger than 60 years. 11 It must be emphasised, however, that the majority of those studies were not a priori designed to examine survival or HF hospitalisation in older patients nor were they statistically powered to do so.
Moreover, it is important to highlight that the benefits of use of CRT To date, the decision to implant a CRT-D or a CRT-P does not take into account the age of the patient, but rather 1-year life expectancy. 2 Physicians should fully discuss the implications of CRT with older patients including the benefits of implantation and the possibility of complications (eg. phrenic nerve stimulation) or inappropriate shocks.
Such discussions should take into account the patient's health care goals and priorities, including quality versus quantity of life, avoidance of invasive procedures and tolerance of uncertainty. ■
